Aorta-CAD vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imagen Technologies
VS
by Powerful Medical

AI Verdict

Aorta-CAD and PMcardio are adjacent tools in cardiology AI, both aiming to improve cardiac diagnostics but through different modalities. Aorta-CAD focuses on detecting aortic conditions like atherosclerosis and ectasia from chest X-rays, while PMcardio interprets ECGs for a wider range of over 50 cardiac conditions, including arrhythmias and myocardial infarction. Therefore, the choice between them depends on whether the diagnostic need is for X-ray-based aortic assessment or ECG-based cardiac condition interpretation.

Choose Aorta-CAD if…

Choose Aorta-CAD if your practice primarily utilizes chest X-rays and you need AI assistance in detecting early signs of Aortic Atherosclerosis and Aortic Ectasia. This cloud-based software seamlessly integrates into existing X-ray reading workflows, helping both radiologists and primary care physicians improve diagnostic accuracy for these chronic conditions. It's particularly useful for identifying previously undiagnosed ailments and enhancing patient care plans.

View Aorta-CAD →

Choose PMcardio if…

Choose PMcardio if your clinical setting requires rapid and accurate interpretation of ECGs for a wide range of cardiac conditions, especially in emergency or primary care environments where a cardiologist may not be immediately available. This AI platform, accessible via mobile app or web, can detect over 50 cardiac conditions, including critical heart attacks and reduced LVEF, providing expert-level interpretations and actionable recommendations at the point of care.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aorta-CAD PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud-based Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, along with enterprise integrations, providing greater flexibility and accessibility for clinicians at the point of care. Its ability to digitize and interpret ECGs from a simple snapshot further enhances ease of use. Aorta-CAD is cloud-based and integrates into existing X-ray workflows, but PMcardio's multi-platform deployment and snapshot functionality suggest broader usability for diverse clinical settings.

Clinical Value

PMcardio

PMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF, with features like AI explainability. Aorta-CAD, while FDA-cleared and showing a significant reduction in missed diagnoses for aortic atherosclerosis and ectasia on chest X-rays, addresses a narrower scope of conditions. PMcardio's broader diagnostic capabilities and extensive validation studies suggest higher overall clinical value.

Pricing & Value

PMcardio

PMcardio offers a freemium model with a free plan for up to 5 ECG analyses per month, and transparent pricing for its Pro plan. Aorta-CAD requires contacting the company for pricing, which offers less transparency. PMcardio's accessible entry point and clear pricing structure provide better value, especially for individual clinicians or smaller practices.

Enterprise Readiness

PMcardio

Both tools are HIPAA compliant and offer BAA. Aorta-CAD is cloud-based and integrates into existing X-ray workflows. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, along with dedicated plans for teams and organizations, indicating a more robust and flexible offering for larger healthcare systems.

Innovation

PMcardio

PMcardio demonstrates strong innovation with its AI explainability feature (ECGxplainu2122) using heatmaps, detection of 50+ ECG findings including novel markers like reduced LVEF from ECGs, and continuous algorithm improvements. Aorta-CAD utilizes deep learning for detection on chest X-rays and offers an overlay for findings, which is valuable but less explicitly innovative in its described features compared to PMcardio's explainable AI and broader diagnostic scope.

Support & Docs

Tie

Both tools are medical devices and are expected to have comprehensive support and documentation to meet regulatory requirements. However, specific details on the breadth and accessibility of their support and documentation (e.g., online knowledge bases, dedicated support teams, training programs) are not extensively detailed in the provided information for either tool. Therefore, it is difficult to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aorta-CAD PMcardio
Tool Name Aorta-CAD PMcardio
Company Imagen Technologies Powerful Medical
Description FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Primary Diagnostic Focus Aortic Atherosclerosis and Aortic Ectasia on chest X-rays 50+ cardiac conditions on ECGs
Regulatory Clearance FDA-cleared CE-certified
Key Features (Examples) Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia; Cloud-based, software-only medical device; Utilizes deep learning algorithms for analysis. Instant AI-powered ECG interpretations; Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders); Visual AI Explainability with heatmaps.

Videos

Demos, reviews, and walkthroughs featuring Aorta-CAD and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Aorta-CAD is designed for seamless integration into existing X-ray reading workflows without requiring new PACS technology or costly re-training. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, connecting to existing ECG systems and hospital systems for automatic result flow. PMcardio also allows for exporting detailed PDF reports that can be integrated into patients' electronic health records.
Aorta-CAD demonstrated a 62% relative reduction in misses for aortic calcification (suggestive of aortic atherosclerosis) and a 35% relative reduction in misses for dilated aorta (pointing to aortic ectasia) in its clinical trial, with 96% of physicians showing improvement with its assistance. PMcardio has been clinically validated in over 25 studies, with its Core AI ECG Model demonstrating 86% sensitivity and 92% specificity for major ECG abnormalities, and near-perfect accuracy for atrial fibrillation (97% sensitivity and 99% specificity). The Queen of Heartsu2122 platform (PMcardio) showed better sensitivity (92% vs 71%) and specificity (81% vs 29%) than standard processes for detecting angiographically confirmed STEMI.
Aorta-CAD is designed to integrate seamlessly into existing X-ray reading workflows without requiring costly re-training of physicians. PMcardio aims to ease the learning curve with a brief guide for digitizing ECGs, focusing on matching the ECG pictogram to the recording layout and ensuring horizontal positioning of leads.
Aorta-CAD assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. PMcardio interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI, various rhythms, reduced LVEF, and conduction disorders. PMcardio also offers AI-powered screening for structural heart disease and analysis of ambulatory ECG recordings.
PMcardio for Organizations includes features to track pathway performance across sites and teams, with dashboards and reporting to support QA, audits, protocol optimization, and registry compliance. The PMcardio Pro Plan for individuals also offers detailed ECG report history for documentation, audits, or teaching.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.